Revision as of 20:05, 3 March 2021 editJWBE (talk | contribs)Extended confirmed users10,129 edits added Category:Hydroxymethyl compounds using HotCat← Previous edit | Revision as of 06:19, 1 April 2021 edit undoProcyonidae (talk | contribs)Extended confirmed users3,427 edits →External links: add cat biomarkersNext edit → | ||
Line 60: | Line 60: | ||
] | ] | ||
] | ] | ||
] | |||
Revision as of 06:19, 1 April 2021
Names | |
---|---|
IUPAC name 7-Methylguanosine | |
Other names N7-Methylguanosine; 2-Amino-1,6-dihydro-7-methyl-6-oxo-9-β-D-ribofuranosylpurinium | |
Identifiers | |
CAS Number | |
3D model (JSmol) | |
Abbreviations | m7G; mG |
ChEBI | |
ChemSpider | |
PubChem CID | |
UNII | |
InChI
| |
SMILES
| |
Properties | |
Chemical formula | C11H16N5O5 |
Molar mass | 298.279 g·mol |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C , 100 kPa). N verify (what is ?) Infobox references |
7-Methylguanosine (mG) is a modified purine nucleoside. It is a methylated version of guanosine and when found in human urine, it may be a biomarker of some types of cancer. In the RNAs, 7-methylguanosine have been used to study and examine the reaction evolving methylguanosine. It also plays a role in mRNA as a blocking group at its 5´-end.
See also
References
- Reynaud, C; Bruno, C; Boullanger, P; Grange, J; Barbesti, S; Niveleau, A (1992). "Monitoring of urinary excretion of modified nucleosides in cancer patients using a set of six monoclonal antibodies". Cancer Letters. 61 (3): 255–62. doi:10.1016/0304-3835(92)90296-8. PMID 1739950.
External links
- Metabocard for 7-Methylguanosine (HMDB01107), Human Metabolome Database, University of Alberta
This article about an organic compound is a stub. You can help Misplaced Pages by expanding it. |